ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
25 hedge funds and large institutions have $5.64M invested in Oncternal Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
25
Holding in Top 10
–
Calls
$5K
Puts
–
Top Buyers
| 1 | +$2.39M | |
| 2 | +$661K | |
| 3 | +$491K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$442K |
| 5 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
+$382K |
Top Sellers
| 1 | -$113K | |
| 2 | -$89K | |
| 3 | -$73K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$60K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$31.8K |